MyFinsight
Home
Blog
About
Contact
Proceeds from warrant
inducement, net of issuance...
$2,866K
Net cash provided by
financing activities
$2,866K
Net increase
(decrease) in cash and cash...
-$355K
Canceled cashflow
$2,866K
Warrant inducement
expense
$4,145K
Change in fair value of
revenue interest...
-$1,820K
Change in fair value of
debt
$750K
Stock-based compensation
$638K
Provision for inventory
$433K
Accounts receivable
-$365K
Issuance costs
associated with warrants...
$222K
Inventory
-$176K
Prepaid expenses, other
current and long-term...
-$172K
Depreciation and
amortization
$171K
Non-cash lease expense
$119K
Unrealized exchange (gain)
loss
-$90K
Net cash used in
operating activities
-$3,221K
Canceled cashflow
$9,101K
Revenue
$2,947K
Net loss
-$6,095K
Canceled cashflow
$2,947K
Change in fair value of
warrant liabilities
-$4,324K
Accrued expenses and
other current...
-$1,363K
Accounts payable
-$347K
Change in fair value of
share obligation
-$120K
Lease liabilities
-$73K
General and
administrative
$2,744K
Other segment items
-$2,364K
Cost of revenue
$1,718K
Sales and marketing
$1,304K
Research and
development-Clinical Trials And...
$343K
Research and
development-Quality And Regulatory
$266K
Research and
development-Product Development
$205K
Research and
development-Digital
$98K
Back
Back
Cash Flow
ALLURION TECHNOLOGIES, INC. (ALURW)
ALLURION TECHNOLOGIES, INC. (ALURW)
source: myfinsight.com